284 related articles for article (PubMed ID: 25779943)
41. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.
Salido M; Martinez-Avilés L; Ademà V; Ferrer A; Espinet B; Garcia M; Salar A; Besses C; Florensa L; Serrano S; Bellosillo B; Solé F
Leuk Res; 2011 Mar; 35(3):e23-4. PubMed ID: 21087793
[No Abstract] [Full Text] [Related]
42. Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M; López C; Navarro A; Frigola G; Nadeu F; Clot G; Bastidas-Mora G; Alcoceba M; Baptista MJ; Blanes M; Colomer D; Costa D; Domingo-Domènech E; Enjuanes A; Escoda L; Forcada P; Giné E; Lopez-Guerra M; Ramón O; Rivas-Delgado A; Vicente Folch L; Wotherspoon A; Climent F; Campo E; López-Guillermo A; Matutes E; Beà S
Blood Adv; 2023 Jul; 7(14):3695-3709. PubMed ID: 36995085
[TBL] [Abstract][Full Text] [Related]
43. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
44. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Alderuccio JP; Lossos IS
Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
[TBL] [Abstract][Full Text] [Related]
45. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
46. Splenic marginal-zone lymphoma: ontogeny and genetics.
Baliakas P; Strefford JC; Bikos V; Parry M; Stamatopoulos K; Oscier D
Leuk Lymphoma; 2015 Feb; 56(2):301-10. PubMed ID: 24798744
[TBL] [Abstract][Full Text] [Related]
47. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Okosun J; Bödör C; Wang J; Araf S; Yang CY; Pan C; Boller S; Cittaro D; Bozek M; Iqbal S; Matthews J; Wrench D; Marzec J; Tawana K; Popov N; O'Riain C; O'Shea D; Carlotti E; Davies A; Lawrie CH; Matolcsy A; Calaminici M; Norton A; Byers RJ; Mein C; Stupka E; Lister TA; Lenz G; Montoto S; Gribben JG; Fan Y; Grosschedl R; Chelala C; Fitzgibbon J
Nat Genet; 2014 Feb; 46(2):176-181. PubMed ID: 24362818
[TBL] [Abstract][Full Text] [Related]
48. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
[TBL] [Abstract][Full Text] [Related]
49. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
50. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
51. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
[TBL] [Abstract][Full Text] [Related]
52. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
Philip AZ
J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
[TBL] [Abstract][Full Text] [Related]
53. NF-κB deregulation in splenic marginal zone lymphoma.
Spina V; Rossi D
Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
[TBL] [Abstract][Full Text] [Related]
54. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
55. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
56. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
[TBL] [Abstract][Full Text] [Related]
57. NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
Martinez D; Navarro A; Martinez-Trillos A; Molina-Urra R; Gonzalez-Farre B; Salaverria I; Nadeu F; Enjuanes A; Clot G; Costa D; Carrio A; Villamor N; Colomer D; Martinez A; Bens S; Siebert R; Wotherspoon A; Beà S; Matutes E; Campo E
Am J Surg Pathol; 2016 Feb; 40(2):192-201. PubMed ID: 26426381
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.
Sol Mateo M; Mollejo M; Villuendas R; Algara P; Sánchez-Beato M; Martinez-Delgado B; Martínez P; Piris MA
Mol Pathol; 1998 Oct; 51(5):262-7. PubMed ID: 10193520
[TBL] [Abstract][Full Text] [Related]
59. Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.
Traverse-Glehen A; Verney A; Gazzo S; Jallades L; Chabane K; Hayette S; Coiffier B; Callet-Bauchu E; Ffrench M; Felman P; Berger F; Baseggio L; Salles G
Leuk Lymphoma; 2017 Mar; 58(3):666-675. PubMed ID: 27347751
[TBL] [Abstract][Full Text] [Related]
60. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
